Clinical Trial

The Faroese Knee Cohort: Etiology and Long-term Implications of Trochlear Dysplasia and Patellar Dislocations.

Study acronym: FKC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2023 (before its estimated November 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
The investigators intend to establish a national cohort including all persons in the ages from 15-20 years old with patellar instability (PI) or a prior knee injury (ACL-ruptur or meniscus damage) . The cohort will be nicknamed "The Faroese Knee Cohort". The overall aim is to investigate two groups. 1. The patella instability group, in which we intend to investigate the following. * Prevalence of patellar dislocation and trochlear dysplasia in the Faroe Islands. * Risk factors for patellar dislocations- * Heredity of trochlear dysplasia. * If there is a specific gene responsible for the development of trochlear dysplasia. * The development of retropatellar artrhosis, its onset and its impact on quality of life and function, 2. Knee injury group (ACL-ruptur or meniscus injury) * The prevalence of ACL-rupture and/or meniscus injury in this specific group in the Faroe Islands. * The impact on quality of life and function.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-10-23; most recent amendment 2023-02-15.
Status change: Not Yet Recruiting → Recruiting 2022-05-27
Trial Details
NCT Number NCT04607538
Lead Sponsor Hvidovre University Hospital
Conditions Patellar Dislocation, ACL Injury, Meniscus Lesion, Trochlear Dysplasia
Enrollment 100 participants
Start Date 2022-03-01
Primary Completion 2024-11-01 (estimated)
Study Completion 2051-12-01 (estimated)
Updated on ClinicalTrials.gov 2023-02-17